3455 — Healthcare & Medical Investment Cashflow Statement
0.000.00%
- ¥42bn
- ¥83bn
- ¥5bn
- 26
- 45
- 38
- 26
Annual cashflow statement for Healthcare & Medical Investment, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.
2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,833 | 2,015 | 2,348 | 2,106 | 2,043 |
| Depreciation | |||||
| Non-Cash Items | 316 | 326 | 378 | 448 | 516 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -122 | -193 | 919 | -219 | -463 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,968 | 3,179 | 4,769 | 3,491 | 3,298 |
| Capital Expenditures | -1,044 | -12,518 | -2,409 | -2,935 | -1,684 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 60 | 137 | 15.2 | -52.6 | -98 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -984 | -12,381 | -2,394 | -2,988 | -1,782 |
| Financing Cash Flow Items | -62.2 | -244 | -148 | -207 | -91 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,074 | 9,040 | -2,135 | -48.3 | -1,238 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -89.3 | -162 | 240 | 455 | 278 |